Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis
Clinical trial NCT02907749 · COMPLETED
Trial details
- NCT number
- NCT02907749
- Sponsor
- Changqing Yang
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2020-01-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.